ArticleFrontiers in physiology2026
HDL-related lipid ratios reflecting metabolic inflammation are associated with endometriosis status and ASRM stage.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation is central to the pathogenesis of endometriosis. High-density lipoprotein (HDL)-related lipid ratios have been proposed as indicators of systemic metabolic inflammation, yet their associations with endometriosis status and ASRM stage remain unclear. Methods: A total of 5,161 women were included, comprising 113 surgically confirmed endometriosis patients and 5,048 women without endometriosis. Multivariable logistic regression was used to evaluate the associations between four HDL-related lipid ratios-lymphocyte-to-HDL ratio (LHR), monocyte-to-HDL ratio (MHR), neutrophil-to-HDL ratio (NHR), and non-HDL-to-HDL ratio (NHHR)-and endometriosis status, with propensity score matching (PSM) applied to assess robustness. Among women with endometriosis, analyses were restricted to 105 patients with complete revised American Society for Reproductive Medicine (ASRM) staging data. Multivariable logistic regression was used to examine the associations between HDL-related lipid ratios and ASRM stage (early vs. advanced), with inverse probability of treatment weighting (IPTW) applied for robustness assessment. Receiver operating characteristic (ROC) curves were constructed to evaluate discriminative performance. Results: LHR was inversely associated with endometriosis status (OR = 0.52, 95% CI: 0.30-0.90), whereas MHR (OR = 3.30, 95% CI: 2.02-5.39), NHR (OR = 4.32, 95% CI: 2.77-6.78), and NHHR (OR = 2.14, 95% CI: 1.20-3.78) were positively associated. All four HDL-related lipid ratios were significantly associated with advanced ASRM stage relative to early-stage disease, including LHR (OR = 3.97, 95% CI: 1.14-15.7), MHR (OR = 6.60, 95% CI: 1.96-26.8), NHR (OR = 4.65, 95% CI: 1.50-16.8), and NHHR (OR = 8.03, 95% CI: 1.47-54.3). PSM and IPTW confirmed the robustness of these associations. ROC results showed that MHR had the highest AUC for ASRM stage classification (0.763), whereas NHR had the highest AUC for endometriosis status classification (0.715). Conclusion: HDL-related lipid ratios are significantly associated with endometriosis status and ASRM stage. These findings suggest the potential utility of HDL-related lipid ratios as adjunctive indicators for clinical stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.